La bourse ferme dans 7 h 16 min
  • CAC 40

    6 246,06
    +11,92 (+0,19 %)
     
  • Euro Stoxx 50

    4 002,23
    +8,80 (+0,22 %)
     
  • Dow Jones

    34 035,99
    +305,10 (+0,90 %)
     
  • EUR/USD

    1,1988
    +0,0011 (+0,10 %)
     
  • Gold future

    1 764,40
    -2,40 (-0,14 %)
     
  • BTC-EUR

    51 519,12
    -1 661,85 (-3,12 %)
     
  • CMC Crypto 200

    1 374,76
    -6,18 (-0,45 %)
     
  • Pétrole WTI

    63,53
    +0,07 (+0,11 %)
     
  • DAX

    15 329,82
    +74,49 (+0,49 %)
     
  • FTSE 100

    7 000,50
    +17,00 (+0,24 %)
     
  • Nasdaq

    14 038,76
    +180,92 (+1,31 %)
     
  • S&P 500

    4 170,42
    +45,76 (+1,11 %)
     
  • Nikkei 225

    29 683,37
    +40,68 (+0,14 %)
     
  • HANG SENG

    29 012,27
    +219,13 (+0,76 %)
     
  • GBP/USD

    1,3755
    -0,0030 (-0,21 %)
     

Global Wide Field Imaging Devices Market to Reach $716.1 Million by 2027

ReportLinker
·27 min de lecture

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 7. - Influencer Pool: 1217. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 05, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Wide Field Imaging Devices Industry" - https://www.reportlinker.com/p06033303/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.



Abstract:
- Global Wide Field Imaging Devices Market to Reach $716.1 Million by 2027
- Amid the COVID-19 crisis, the global market for Wide Field Imaging Devices estimated at US$491.7 Million in the year 2020, is projected to reach a revised size of US$716.1 Million by 2027, growing at aCAGR of 5.5% over the period 2020-2027. Table Top, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$476.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hand-Held segment is readjusted to a revised 5.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $133.2 Million, While China is Forecast to Grow at 8.4% CAGR
- The Wide Field Imaging Devices market in the U.S. is estimated at US$133.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$149.4 Million by the year 2027 trailing a CAGR of 8.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Select Competitors (Total 42 Featured) -

  • Carl Zeiss Meditec AG

  • Centervue S.P.A.

  • Clarity Medical Systems, Inc.

  • Epipole Ltd.

  • Forus Health Pvt Ltd

  • Heidelberg Engineering Inc.

  • Medibell Medical Vision Technologies Ltd

  • oDocs Eye Care

  • Optos

  • Phoenix Technology Group, LLC




Read the full report: https://www.reportlinker.com/p06033303/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Wide Field Imaging Devices Competitor Market Share Scenario
Worldwide (in %): 2020E
Global Competitor Market Shares by Segment

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Wide Field Imaging
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Wide Field Imaging Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Wide Field Imaging
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for Table Top by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Table Top by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Table Top by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Hand-Held by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Hand-Held by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Hand-Held by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Specialty Clinics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Specialty Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Specialty Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Ambulatory
Surgical Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Ambulatory Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Ambulatory Surgical
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 19: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Diabetic
Retinopathy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Diabetic Retinopathy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Diabetic Retinopathy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Retinopathy of
Prematurity by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Retinopathy of Prematurity
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Retinopathy of
Prematurity by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 28: World Current & Future Analysis for Retinal Vein
Occlusion by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Retinal Vein Occlusion by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Retinal Vein Occlusion
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Uveitis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Uveitis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Uveitis by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Choroidal
Melanoma by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 35: World Historic Review for Choroidal Melanoma by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Choroidal Melanoma by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 37: World Current & Future Analysis for Hemoglobinopathy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 38: World Historic Review for Hemoglobinopathy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: World 15-Year Perspective for Hemoglobinopathy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 40: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 41: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 42: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
Market Analytics
Table 43: USA Current & Future Analysis for Wide Field Imaging
Devices by Type - Table Top and Hand-Held - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: USA Historic Review for Wide Field Imaging Devices by
Type - Table Top and Hand-Held Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 45: USA 15-Year Perspective for Wide Field Imaging
Devices by Type - Percentage Breakdown of Value Sales for Table
Top and Hand-Held for the Years 2012, 2020 & 2027

Table 46: USA Current & Future Analysis for Wide Field Imaging
Devices by End-Use - Hospitals, Specialty Clinics, Ambulatory
Surgical Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 47: USA Historic Review for Wide Field Imaging Devices by
End-Use - Hospitals, Specialty Clinics, Ambulatory Surgical
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 48: USA 15-Year Perspective for Wide Field Imaging
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Specialty Clinics, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2020 & 2027

Table 49: USA Current & Future Analysis for Wide Field Imaging
Devices by Application - Diabetic Retinopathy, Retinopathy of
Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal
Melanoma, Hemoglobinopathy and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 50: USA Historic Review for Wide Field Imaging Devices by
Application - Diabetic Retinopathy, Retinopathy of Prematurity,
Retinal Vein Occlusion, Uveitis, Choroidal Melanoma,
Hemoglobinopathy and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 51: USA 15-Year Perspective for Wide Field Imaging
Devices by Application - Percentage Breakdown of Value Sales
for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal
Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy
and Other Applications for the Years 2012, 2020 & 2027

CANADA
Table 52: Canada Current & Future Analysis for Wide Field
Imaging Devices by Type - Table Top and Hand-Held - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: Canada Historic Review for Wide Field Imaging Devices
by Type - Table Top and Hand-Held Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 54: Canada 15-Year Perspective for Wide Field Imaging
Devices by Type - Percentage Breakdown of Value Sales for Table
Top and Hand-Held for the Years 2012, 2020 & 2027

Table 55: Canada Current & Future Analysis for Wide Field
Imaging Devices by End-Use - Hospitals, Specialty Clinics,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 56: Canada Historic Review for Wide Field Imaging Devices
by End-Use - Hospitals, Specialty Clinics, Ambulatory Surgical
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 57: Canada 15-Year Perspective for Wide Field Imaging
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Specialty Clinics, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2020 & 2027

Table 58: Canada Current & Future Analysis for Wide Field
Imaging Devices by Application - Diabetic Retinopathy,
Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis,
Choroidal Melanoma, Hemoglobinopathy and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: Canada Historic Review for Wide Field Imaging Devices
by Application - Diabetic Retinopathy, Retinopathy of
Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal
Melanoma, Hemoglobinopathy and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 60: Canada 15-Year Perspective for Wide Field Imaging
Devices by Application - Percentage Breakdown of Value Sales
for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal
Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy
and Other Applications for the Years 2012, 2020 & 2027

JAPAN
Table 61: Japan Current & Future Analysis for Wide Field
Imaging Devices by Type - Table Top and Hand-Held - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: Japan Historic Review for Wide Field Imaging Devices
by Type - Table Top and Hand-Held Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 63: Japan 15-Year Perspective for Wide Field Imaging
Devices by Type - Percentage Breakdown of Value Sales for Table
Top and Hand-Held for the Years 2012, 2020 & 2027

Table 64: Japan Current & Future Analysis for Wide Field
Imaging Devices by End-Use - Hospitals, Specialty Clinics,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 65: Japan Historic Review for Wide Field Imaging Devices
by End-Use - Hospitals, Specialty Clinics, Ambulatory Surgical
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 66: Japan 15-Year Perspective for Wide Field Imaging
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Specialty Clinics, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2020 & 2027

Table 67: Japan Current & Future Analysis for Wide Field
Imaging Devices by Application - Diabetic Retinopathy,
Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis,
Choroidal Melanoma, Hemoglobinopathy and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Japan Historic Review for Wide Field Imaging Devices
by Application - Diabetic Retinopathy, Retinopathy of
Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal
Melanoma, Hemoglobinopathy and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 69: Japan 15-Year Perspective for Wide Field Imaging
Devices by Application - Percentage Breakdown of Value Sales
for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal
Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy
and Other Applications for the Years 2012, 2020 & 2027

CHINA
Table 70: China Current & Future Analysis for Wide Field
Imaging Devices by Type - Table Top and Hand-Held - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 71: China Historic Review for Wide Field Imaging Devices
by Type - Table Top and Hand-Held Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 72: China 15-Year Perspective for Wide Field Imaging
Devices by Type - Percentage Breakdown of Value Sales for Table
Top and Hand-Held for the Years 2012, 2020 & 2027

Table 73: China Current & Future Analysis for Wide Field
Imaging Devices by End-Use - Hospitals, Specialty Clinics,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 74: China Historic Review for Wide Field Imaging Devices
by End-Use - Hospitals, Specialty Clinics, Ambulatory Surgical
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 75: China 15-Year Perspective for Wide Field Imaging
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Specialty Clinics, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2020 & 2027

Table 76: China Current & Future Analysis for Wide Field
Imaging Devices by Application - Diabetic Retinopathy,
Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis,
Choroidal Melanoma, Hemoglobinopathy and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: China Historic Review for Wide Field Imaging Devices
by Application - Diabetic Retinopathy, Retinopathy of
Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal
Melanoma, Hemoglobinopathy and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: China 15-Year Perspective for Wide Field Imaging
Devices by Application - Percentage Breakdown of Value Sales
for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal
Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy
and Other Applications for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
Market Analytics
Table 79: Europe Current & Future Analysis for Wide Field
Imaging Devices by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 80: Europe Historic Review for Wide Field Imaging Devices
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 81: Europe 15-Year Perspective for Wide Field Imaging
Devices by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 82: Europe Current & Future Analysis for Wide Field
Imaging Devices by Type - Table Top and Hand-Held - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: Europe Historic Review for Wide Field Imaging Devices
by Type - Table Top and Hand-Held Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 84: Europe 15-Year Perspective for Wide Field Imaging
Devices by Type - Percentage Breakdown of Value Sales for Table
Top and Hand-Held for the Years 2012, 2020 & 2027

Table 85: Europe Current & Future Analysis for Wide Field
Imaging Devices by End-Use - Hospitals, Specialty Clinics,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 86: Europe Historic Review for Wide Field Imaging Devices
by End-Use - Hospitals, Specialty Clinics, Ambulatory Surgical
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 87: Europe 15-Year Perspective for Wide Field Imaging
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Specialty Clinics, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2020 & 2027

Table 88: Europe Current & Future Analysis for Wide Field
Imaging Devices by Application - Diabetic Retinopathy,
Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis,
Choroidal Melanoma, Hemoglobinopathy and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: Europe Historic Review for Wide Field Imaging Devices
by Application - Diabetic Retinopathy, Retinopathy of
Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal
Melanoma, Hemoglobinopathy and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 90: Europe 15-Year Perspective for Wide Field Imaging
Devices by Application - Percentage Breakdown of Value Sales
for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal
Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy
and Other Applications for the Years 2012, 2020 & 2027

FRANCE
Table 91: France Current & Future Analysis for Wide Field
Imaging Devices by Type - Table Top and Hand-Held - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 92: France Historic Review for Wide Field Imaging Devices
by Type - Table Top and Hand-Held Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 93: France 15-Year Perspective for Wide Field Imaging
Devices by Type - Percentage Breakdown of Value Sales for Table
Top and Hand-Held for the Years 2012, 2020 & 2027

Table 94: France Current & Future Analysis for Wide Field
Imaging Devices by End-Use - Hospitals, Specialty Clinics,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 95: France Historic Review for Wide Field Imaging Devices
by End-Use - Hospitals, Specialty Clinics, Ambulatory Surgical
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 96: France 15-Year Perspective for Wide Field Imaging
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Specialty Clinics, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2020 & 2027

Table 97: France Current & Future Analysis for Wide Field
Imaging Devices by Application - Diabetic Retinopathy,
Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis,
Choroidal Melanoma, Hemoglobinopathy and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: France Historic Review for Wide Field Imaging Devices
by Application - Diabetic Retinopathy, Retinopathy of
Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal
Melanoma, Hemoglobinopathy and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 99: France 15-Year Perspective for Wide Field Imaging
Devices by Application - Percentage Breakdown of Value Sales
for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal
Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy
and Other Applications for the Years 2012, 2020 & 2027

GERMANY
Table 100: Germany Current & Future Analysis for Wide Field
Imaging Devices by Type - Table Top and Hand-Held - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 101: Germany Historic Review for Wide Field Imaging
Devices by Type - Table Top and Hand-Held Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 102: Germany 15-Year Perspective for Wide Field Imaging
Devices by Type - Percentage Breakdown of Value Sales for Table
Top and Hand-Held for the Years 2012, 2020 & 2027

Table 103: Germany Current & Future Analysis for Wide Field
Imaging Devices by End-Use - Hospitals, Specialty Clinics,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 104: Germany Historic Review for Wide Field Imaging
Devices by End-Use - Hospitals, Specialty Clinics, Ambulatory
Surgical Centers and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 105: Germany 15-Year Perspective for Wide Field Imaging
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Specialty Clinics, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2020 & 2027

Table 106: Germany Current & Future Analysis for Wide Field
Imaging Devices by Application - Diabetic Retinopathy,
Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis,
Choroidal Melanoma, Hemoglobinopathy and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: Germany Historic Review for Wide Field Imaging
Devices by Application - Diabetic Retinopathy, Retinopathy of
Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal
Melanoma, Hemoglobinopathy and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 108: Germany 15-Year Perspective for Wide Field Imaging
Devices by Application - Percentage Breakdown of Value Sales
for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal
Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy
and Other Applications for the Years 2012, 2020 & 2027

ITALY
Table 109: Italy Current & Future Analysis for Wide Field
Imaging Devices by Type - Table Top and Hand-Held - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 110: Italy Historic Review for Wide Field Imaging Devices
by Type - Table Top and Hand-Held Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 111: Italy 15-Year Perspective for Wide Field Imaging
Devices by Type - Percentage Breakdown of Value Sales for Table
Top and Hand-Held for the Years 2012, 2020 & 2027

Table 112: Italy Current & Future Analysis for Wide Field
Imaging Devices by End-Use - Hospitals, Specialty Clinics,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 113: Italy Historic Review for Wide Field Imaging Devices
by End-Use - Hospitals, Specialty Clinics, Ambulatory Surgical
Centers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 114: Italy 15-Year Perspective for Wide Field Imaging
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Specialty Clinics, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2020 & 2027

Table 115: Italy Current & Future Analysis for Wide Field
Imaging Devices by Application - Diabetic Retinopathy,
Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis,
Choroidal Melanoma, Hemoglobinopathy and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 116: Italy Historic Review for Wide Field Imaging Devices
by Application - Diabetic Retinopathy, Retinopathy of
Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal
Melanoma, Hemoglobinopathy and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 117: Italy 15-Year Perspective for Wide Field Imaging
Devices by Application - Percentage Breakdown of Value Sales
for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal
Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy
and Other Applications for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 118: UK Current & Future Analysis for Wide Field Imaging
Devices by Type - Table Top and Hand-Held - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 119: UK Historic Review for Wide Field Imaging Devices by
Type - Table Top and Hand-Held Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 120: UK 15-Year Perspective for Wide Field Imaging
Devices by Type - Percentage Breakdown of Value Sales for Table
Top and Hand-Held for the Years 2012, 2020 & 2027

Table 121: UK Current & Future Analysis for Wide Field Imaging
Devices by End-Use - Hospitals, Specialty Clinics, Ambulatory
Surgical Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 122: UK Historic Review for Wide Field Imaging Devices by
End-Use - Hospitals, Specialty Clinics, Ambulatory Surgical

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033303/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001